Several pathophysiological mechanisms explain the complications related to obesity in COVID-19, including increased ACE-2 expression in adipose tissue, chronic inflammation, amplification of the proinflammatory response, endothelial damage, and hypercoagulability [42]. The gene discussed is ACE2; the disease is COVID-19.